An Adjuvant Therapy for Tubercular Meningitis.
D004926:Escherichia coli; D007536:Isomerism; D008837:Micrococcus / Q000150:complications* / Q000472:pathogenicity*; D009525:Niacin; D009539:Nicotinic Acids / Q000627:therapeutic use*; D013307:Streptomycin / Q000627:therapeutic use*; D014376:Tuberculosis; D014390:Tuberculosis, Meningeal / Q000150:complications*
D009539:Nicotinic Acids; D009525:Niacin; D013307:Streptomycin
ESCHERICHIA COLI; MICROCOCCAL INFECTIONS/complications; NICOTINIC ACID ISOMERS/therapeutic use; STREPTOMYCIN/therapeutic use; TUBERCULOSIS, MENINGEAL/complications
Eine Adjuvans-Therapie der tuberkulösen Meningitis.